Trading Signals: ALLK Stock Price Prediction and Forecast (Thu. Jul. 19, 2018 - Fri. May. 13, 2022)(Allakos Inc)
| ALLK latest price $59.5400 (-10.3%) ($58.5900 - $66.9900) on Thu. Mar. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.78% (three month average) | RSI | 31 | Latest Price | $59.5400(-10.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ALLK declines -0.8% a day on average for past five trading days. | Weekly Trend | ALLK declines -1.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ALLK advance at 0% a week (0% probability) XBI(45%) IBB(42%) ARKG(41%) ARKK(38%) IWO(37%) | Factors Impacting ALLK price | ALLK will decline at least -1.89% in a week (0% probabilities). VIXM(-25%) VXX(-24%) TLT(-11%) BNDX(-6%) SHY(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.89% (StdDev 3.78%) | Hourly BBV | 0 () | Intraday Trend | -8.7% | | | |
|
1 - 5 Day Possible Target | $55.73(-6.4%) | Resistance Level | $65.37 | 5 Day Moving Average | $63.48(-6.21%) | 10 Day Moving Average | $63.68(-6.5%) | 20 Day Moving Average | $65.37(-8.92%) | To recent high | -55.1% | To recent low | 0% | Market Cap | $2.912b | | | | Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in Redwood, CA. |